Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine
George D. Demetri, Patrick Schöffski, Giovanni Grignani, Jean Yves Blay, Robert G. Maki, Brian A. Van Tine, Thierry Alcindor, Robin L. Jones, David R. D’Adamo, Matthew Guo, Sant Chawla
Dive into the research topics of 'Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine'. Together they form a unique fingerprint.